Related Experiment Videos
Cataracts in childhood leukaemia
The British Journal of Ophthalmology
|June 1, 1985
Summary
Cataract development was studied in children treated for acute lymphoblastic leukemia. Many showed lens opacities, with boys more affected, highlighting potential vision risks for pediatric cancer survivors.
Area of Science:
- Pediatric Oncology
- Ophthalmology
- Hematology
Background:
- Acute lymphoblastic leukemia (ALL) treatment often involves corticosteroids and cranial irradiation.
- Long-term side effects of ALL treatment can impact various organ systems, including the eyes.
Purpose of the Study:
- To investigate the incidence and severity of cataract in children post-ALL treatment.
- To identify potential risk factors associated with cataract development in this cohort.
Main Methods:
- A cohort of 37 children who completed ALL treatment was assessed for lens opacities.
- Ophthalmological examinations were performed to evaluate cataract presence and characteristics.
Main Results:
- Twelve out of 37 children (32%) developed posterior subcapsular lens opacities.
- No clear dose-response relationship was found between treatment (corticosteroids, cranial irradiation) and cataract severity.
- Boys exhibited more severe lens opacities compared to girls.
Conclusions:
- Children treated for ALL have a notable incidence of posterior subcapsular lens opacities.
- While opacities were not optically significant, awareness of potential vision risks is crucial for clinicians managing pediatric cancer survivors.